Professional Documents
Culture Documents
Equity Research Lab 30 March Nifty Report
Equity Research Lab 30 March Nifty Report
http://www.equityresearchlab.com
Nifty Future
R1: 7664
R2:7708
R3: 7741
Pivot: 7630
S1: 7586
S2:7553
S3:7509
CHART INTERPRETATION
INDEX OUTLOOK
NIFTY FUTURE:- Nifty future closed at
7620.05 on Tuesday. The nifty falling below
7600-mark. Healthcare, infra, FMCG and
technology stocks dragged market while rally
in auto, metals and select banks stocks
capped downside.
INTRADAY STRATIGY:- Buy Nifty above 7600
for the tgt of 7650-7700 with the sl of 7530.
SECTORIAL INDICES
INDEX OUTLOOK
Lupin dropped 6.17% to Rs 1,402, in volatile trade after the
company clarified that it does not expect any disruption to
product supply from the Mandideep location.
Aurobindo Pharma has received final approval from USFDA to
manufacture and market Rivastigmine Tartrate Capsules USP,
used for the treatment of dementia disease, in the American
market.
Ashok Leyland has received orders worth Rs 800 crore from
the Indian armed forces. As part of the order, the company will
supply 450 units of Field Artillery Tractor (FAT) 6x6 and other
similar super stallion vehicles, and 825 units of ambulance
4x4.AI).
Nifty Tips
Equity TIPS
Forex Tips
Free Trial
Commodity
Tips
MCX Tips
Stock Cash
Tips
Thank you !
http://www.equityresearchlab.com